Sally Bowden
Keine laufenden Positionen mehr
Profil
Sally Bowden served as President & CEO at Samco & Associates, Inc. and as Vice President of Quality & Process Improvement at Ventana Medical Systems, Inc. She also held the position of Vice President of Quality & Regulatory Compliance at Roche Diagnostics Corp.
From 2013 to 2018, she was the VP of Regulatory Affairs, QA & Operations at Vigilant Biosciences, Inc. and from 2018 to 2023, she served as Head of Regulatory Affairs at Renalytix Plc.
Prior to her industry career, she was an Associate Professor at Purdue School of Engineering & Technology.
Bowden holds a Master's in Business Administration from Indiana Wesleyan University and an undergraduate degree from Purdue University School of Mechanical Engineering.
Ehemalige bekannte Positionen von Sally Bowden
| Unternehmen | Position | Ende |
|---|---|---|
| RENALYTIX PLC | General Counsel | 01.03.2023 |
Vigilant Biosciences, Inc.
 Vigilant Biosciences, Inc. Medical/Nursing ServicesHealth Services Vigilant Biosciences, Inc. engages in the innovation and development of solutions that aid in the early detection and intervention of cancer. It offers an oral cancer screening kit that include point-of-care product. The firm's products include OncAlert Oral Cancer RAPID Test and OncAlert Oral Cancer LAB Test. The company was founded by Matthew H. J. Kim and Elizabeth Franzmann in 2011 and is headquartered in Fort Lauderdale, FL. | Chief Operating Officer | 01.01.2018 |
| Purdue School of Engineering & Technology | Corporate Officer/Principal | - |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | - |
Ausbildung von Sally Bowden
| Indiana Wesleyan University | Masters Business Admin |
| Purdue University School of Mechanical Engineering | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RENALYTIX PLC | Technology Services |
| Private Unternehmen | 4 |
|---|---|
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
Vigilant Biosciences, Inc.
Vigilant Biosciences, Inc. Medical/Nursing ServicesHealth Services Vigilant Biosciences, Inc. engages in the innovation and development of solutions that aid in the early detection and intervention of cancer. It offers an oral cancer screening kit that include point-of-care product. The firm's products include OncAlert Oral Cancer RAPID Test and OncAlert Oral Cancer LAB Test. The company was founded by Matthew H. J. Kim and Elizabeth Franzmann in 2011 and is headquartered in Fort Lauderdale, FL. | Health Services |
| Samco & Associates, Inc. |
